Видео с ютуба Tucatinib

3 клинических исследования рака молочной железы, которые изменят подход к лечению в 2026 году.

Интеграция тукатиниба и T-DXd при различных стадиях заболевания у пациентов с HER2-положительным ...

TUKYSA (тукатиниб) - Рак молочной железы

HER2CLIMB-05: the role of tucatinib in HER2-positive metastatic breast cancer

HER2CLIMB-05: tucatinib improves progression-free survival in HER2+ metastatic breast cancer

Tucatinib Targeted Therapy and Doxil Chemotherapy for Advanced HER2+ Breast Cancer

HER2+ Brain Mets: Decode Radiation vs Tucatinib-Based Therapy

Post-ADC treatment strategies in HER2+ breast cancer

Exploring Tucatinib's Impact on HER2-Positive Breast Cancer

Pronunciation

Whats The Mechanism Of Action For Tucatinib

Tucatinib and trastuzumab in the treatment paradigm of HER2-positive mCRC

Recent progress in managing brain metastasis in breast cancer

32 month follow-up of MOUNTAINEER: tucatinib and trastuzumab in HER2+ mCRC

TUKYSA (tucatinib)- unresectable or metastatic HER2-positive breast cancer

FDA D.I.S.C.O. Burst Edition: FDA approvals of Tukysa (tucatinib) with trastuzumab for colorectal...

HER2陽性乳癌標靶治療新藥tucatinib(商品名為Tukysa)在腦部轉移治療的概況-2/2

HER2陽性乳癌標靶治療新藥tucatinib(商品名為Tukysa)在腦部轉移治療的概況-1/2

2nd Oncology Beyond the Obvious (OBTO) In-Person Conference | Breast Cancer

TUKYSA (tucatinib)- breast cancer